State NY
Clinical Trials in New York
New York is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New York and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 715 actively recruiting studies with New York sites out of 715 registered in total. The busiest research areas in New York are Breast Cancer, Acute Myeloid Leukemia, Prostate Cancer. Leading sponsors running trials in the state include Memorial Sloan Kettering Cancer Center, Columbia University, NYU Langone Health. By stage, New York trials break down as Phase 1 (141), Phase 2 (219), Phase 3 (136), Phase 4 (27).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New York
Frequently Asked Questions — Clinical Trials in New York
How many clinical trials are currently recruiting in New York?
ClinicalMetric currently tracks 715 actively recruiting clinical trials with at least one location in New York. The total number of registered studies—including active but not currently enrolling trials—is 715. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New York?
New York hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Acute Myeloid Leukemia, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New York serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New York?
To join a clinical trial in New York, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New York maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New York
NCT06445946 Phase 4
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Tr...
Condition
Gestational Diabetes Mellitus
Enrollment
1,572 pts
Location
United States
Sponsor
Ohio State University
NCT07218380 Phase 3
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary T...
Condition
Carcinoma, Transitional Cell
Enrollment
450 pts
Location
United States, Australia, Brazil
Sponsor
Eli Lilly and Company
NCT06611579 N/A
Recruiting
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
Condition
Tricuspid Valve Regurgitation
Enrollment
50 pts
Location
United States, Belgium, Canada
Sponsor
inQB8 Medical Technologies, LL
NCT05985161 Phase 2
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Condition
Wilms Tumor
Enrollment
45 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06977503 N/A
Recruiting
Electrotherapy Stimulation Together With Life Coaching for the Support of Burnou...
Condition
Psychiatric Disorder
Enrollment
40 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT07011927 N/A
Recruiting
Extra-cochlear Electrode Placement at the Post-auricular Vagus Nerve in Cochlear...
Condition
Hearing Loss
Enrollment
12 pts
Location
United States
Sponsor
NYU Langone Health
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
NCT02418442 N/A
Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Condition
Rheumatic Joint Disease
Enrollment
20,000 pts
Location
United States, Canada, Israel
Sponsor
Duke University
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
216 pts
Location
United States
Sponsor
Mayo Clinic
NCT07818382 N/A
Recruiting
Assessing the Relationships Between Parent-child Eating in the Absence of Hunger...
Condition
Eating in Absence of Hunger
Enrollment
70 pts
Location
United States
Sponsor
State University of New York a
NCT06907173 Phase 3
Recruiting
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESE...
Condition
Status Epilepticus
Enrollment
770 pts
Location
United States
Sponsor
University of Virginia
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07100080 Phase 2, Phase 3
Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy...
Condition
Non-Small Cell Lung Cancer
Enrollment
661 pts
Location
United States, Argentina, Belgium
Sponsor
Bristol-Myers Squibb
NCT06828991 Phase 2
Recruiting
A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients...
Condition
Diffuse Large B-Cell Lymphoma (DLBCL)
Enrollment
40 pts
Location
United States
Sponsor
Danielle Wallace
NCT07195903 N/A
Recruiting
The STAND-UP Study
Condition
Orthostatic Hypotension, Dysautonomic
Enrollment
100 pts
Location
United States
Sponsor
St. Francis Hospital, New York
NCT05460520 N/A
Recruiting
DevRobust Treatment for Mal de Débarquement Syndrome
Condition
Mal de Débarquement Syndrome
Enrollment
200 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT07027124 Phase 2
Recruiting
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembroli...
Condition
Prostate Cancer
Enrollment
40 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT06223880 Phase 4
Recruiting
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing t...
Condition
Major Depressive Disorder
Enrollment
350 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT05082181 N/A
Recruiting
Telephone-Based Support Programs for People With Epilepsy
Condition
Epilepsy
Enrollment
120 pts
Location
United States
Sponsor
NYU Langone Health
NCT07143019 N/A
Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked ...
Condition
Hemorrhagic Stroke
Enrollment
214 pts
Location
United States
Sponsor
phenox Inc.
NCT07060807 Phase 3
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Condition
Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05793853 N/A
Recruiting
Hypoparathyroidism Natural History Study
Condition
Hypoparathyroidism
Enrollment
106 pts
Location
United States
Sponsor
Columbia University
NCT06689839 N/A
Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Condition
Aortic Stenosis Treated With TAVI
Enrollment
500 pts
Location
United States, Australia
Sponsor
EnCompass Technologies, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology